State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

All that has medical researchers and companies scrambling to gather more data and develop better tools to assess how ...

George Hampton, CEO of Currax Pharmaceuticals, joins TheStreet to explain what needs to happen in order for weight loss drugs to become covered by insurance companies.

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

The yield has risen 73.6 basis points over the past seven weeks, according to Dow Jones Market Data. On Friday, traders were ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...